WKN DE: A2AE98 / ISIN: GB00BYV81293

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Shield Therapeutics Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
21:57:03	0,068
21:47:21	0,068
21:33:20	0,068
21:17:37	0,068
21:04:00	0,068
20:32:52	0,068
20:18:09	0,068
20:03:03	0,068
19:50:58	0,068
19:31:32	0,068
19:16:18	0,068
19:01:26	0,068
18:31:39	0,068
18:16:53	0,068
18:02:02	0,068
17:31:54	0,068
17:17:16	0,068
17:02:31	0,068
16:32:42	0,068
16:17:26	0,068
15:32:30	0,068
15:17:50	0,068
15:02:37	0,068
14:32:42	0,068
14:17:50	0,068
13:32:07	0,068
13:18:02	0,068
13:03:24	0,068
12:52:07	0,068
12:33:13	0,068
12:18:08	0,068
12:03:24	0,068
11:33:33	0,068
11:18:16	0,068
11:04:09	0,068

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Nachrichten zu Shield Therapeutics PLC

21.11.24		Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
11.11.24		Hardman & Co Video Event: Shield Therapeutics (STX) Investor Forum
11.09.24		Hardman & Co Research on Shield Therapeutics (STX): Focusing on successful execution

Analysen zu Shield Therapeutics PLC

Weitere Meldungen

22:45		Deutsche Bank: Künstliche Intelligenz steigert die Produktivität
22:43		Stock Market Today, June 18: QuantumScape Jumps After Teaming Up With Honda on Solid-State Battery Research Agreement
22:30		USA Rare Earth Now Has $3.5 Billion to Establish a "Mine-to-Magnet" Business That Is Crucial to National Security. Is the Stock a Buy Today?
22:16		Brookfield Is Launching Another Renewable Energy Company. Here's What Investors Need to Know.
22:15		If You Invested $1000 In NVIDIA Stock 5 Years Ago, You Would Have This Much Today
22:09		Anthropic Makes 'Fetch' Happen As New Claude Models Beat Human Teams on Robotics Planning Tasks
22:05		How Much Could $1,000 in SpaceX Stock Be Worth in 3 Years?
22:01		Today's Wordle Hints, Answer and Help for June 19, #1826
22:00		Here's How Much $100 Invested In STMicroelectronics 15 Years Ago Would Be Worth Today
22:00		A Reverse Stock Split Is Coming for Marqeta Shares. Should You Jump In Before It Happens?
21:56		3 Space Stocks to Buy Now That SpaceX Is Off the Table
21:49		What Does Appian CEO's Sale of 50,000 Shares for $1.2 Million Mean for Investors?
21:45		Watch Every Formula 1 Austrian Grand Prix Race Next Weekend for Free on Apple TV
21:45		With SpaceX Ready to Be Included in the Russell 1000 Index, Should You Buy the Vanguard Russell 1000 Growth Index (VONG) ETF?
21:35		iShares vs. Invesco: Which ETF Wins This Consumer Staples Showdown?
21:30		Goldman Sachs Says SpaceX Could Hit $474 Billion in Revenue by 2030. Here Are the 3 AI Stocks That Benefit Most.
21:29		OpenAI, Anthropic IPOs Spark Battle Between Goldman And Morgan Stanley
21:29		TG Therapeutics Stock Rises Thursday: What's Driving The Gains?
21:29		ZIM Executive Sells $287,000 in Stock as Shares Climb 43% Over 12 Months
21:29		Wegen Problemen mit Baustellen auf Autobahnen: Rückruf von 4.000 Waymo-Robotaxis
21:22		First Merchants Stock Up 15%: Why This $835,000 Insider Sale Doesn't Seem Like a Red Flag
21:22		Is Sweetgreen a Millionaire-Maker Stock?
21:15		One Warning Signal AMD Investors Can't Miss
21:13		SoFi Stock Is Rising Thursday: What's Driving The Move?
21:12		UFP Technologies Director Sells $287,000 After Option Exercise as Shares Stay Flat
21:12		An Ex-OpenAI Researcher With $20 Billion Just Built a Neocloud Trifecta: Here Are the 3 Stocks He's Buying.
21:05		Joby Aviation Scores a Win in Its Legal Battle Against Rival Archer Aviation. Will It Help the Slumping Stock?
21:00		Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF
20:55		Employers to college students: Skip the perfect GPA and go get a summer job
20:53		Strategy Stock Is Under Pressure: What's Happening Today?
20:49		Paramount Skydance Shares Edge Higher As Regulators Clear Blockbuster Deal
20:47		'Electronic Nose' Shows Promise for Detecting Food Allergens and Spoilage
20:45		3 Things to Know Before Buying Bank of America Stock
20:40		BlackRock vs. Blackstone: Which Financial Stock Is a Better Buy in 2026?
20:40		How America cheated Black GIs after World War II, contributing to the racial wealth gap
20:39		Federal Energy Regulator Seeks to Limit Conflicts Over Data Centers
20:38		Which Is the Better International ETF, Vanguard's VEA Targeting Developed Markets or Schwab's Emerging Markets-Focused SCHE?
20:33		OpenAI Taps Trump's Former AI Adviser For New Strategy Role
20:30		Mark Your Calendar: SpaceX Stock Could Look Very Different After Earnings
20:22		Penske Media Is Buying What’s Left of Vox Media
20:22		Why Are Roku Investors No Longer Getting $160 a Share in a Bad Buyout?
20:17		Hims & Hers Stock Jumps After Barclays Raises Price Target
20:12		Lyft vs. Uber Technologies: Which Ride Sharing Stock Is a Better Buy in 2026?
20:09		How ‘Toy Story 5’ could help power a major comeback year for Hollywood
20:06		Should You Buy the Honeywell Aerospace Spinoff?
20:05		Deal Dispatch: Yum! Brands Sells Pizza Hut, Fox Corp. Buys Roku For $22 Billion, Salesforce Acquires Fin
20:05		Deal Dispatch: Yum! Brands Sells Pizza Hut, Fox Corp. Buys Roku For $22 Billion, Salesforce Acquires Fin
20:00		Top 10: Der beste ergonomische Bürostuhl im Test - Herman Miller vor Flexispot
19:52		Why Is Cipher Digital Stock Rising On Thursday?
19:51		Gulfport Energy vs. Viper Energy: Is an Energy Producer or Royalty Collector the Better Buy?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: El-Ahram Utopia For Real Estate and Tourist Investment Senurita Food Production Misr National Steel Sky Light for Tourism Development Company

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	18.06.2026 23:27
Kaufwert:	EUR
	Hinzufügen Speichern

Shield Therapeutics Aktie

WKN DE: A2AE98 / ISIN: GB00BYV81293

Shield Therapeutics Times and Sales (STU)

Nachrichten zu Shield Therapeutics PLC

Analysen zu Shield Therapeutics PLC

Weitere Meldungen